A useful starting point for determining which adjunctive surgical closure and securement products are appropriate for different wound healing treatments is to recognize the major distinction between different wound types. Surgical wounds are usually appropriate for treatment with adjunctive surgical closure and securement products because they are created under clean conditions, the usual acute healing cascade of events begins immediately and control of the bleeding and closure process can lead to accelerated healing, improved prognosis, and enhanced aesthetic effects such as reduced scarring.
Surgical wounds offer the potential for devices to ensure hemostasis, prevent internal adhesions and anastomoses, soft tissue securement, and closure of the skin. Traumatic wounds also offer potential for skin closure products and for hemostats, and adhesion prevention during post-trauma surgery. New wound-covering sealant products may also offer potential for treatment of cuts, grazes, and burns.
Chronic wounds are generally not amenable for treatment by adhesives, sealants and hemostats unless the wound has been debrided to a sterile bleeding surface (in which case it becomes like a surgical wound), or the product offers some stimulant activity; many hemostats exhibit some inflammatory and cytokinetic activity, which has been associated with accelerated healing.
To help determine how these applications for closure and securement products may translate into market potential, it is relevant to note the prevalence and rates of growth of the different types of wounds; see below.
Source: MedMarket Diligence, LLC; Report #S175
The potential contribution of newly developed products to the management of these different wounds is discussed later in this section.
Purchase for download: Report #S175, "Sealants, Glues, Wound Closure (2009) PDF" — $3,250.00
MedMarket Diligence has also recently published its "Worldwide Wound Management Market, 2008-2017." Report #S247.